FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways

被引:8
作者
Huang, Min [1 ]
Yao, Fuwen [2 ]
Nie, Litong [1 ]
Wang, Chao [1 ]
Su, Dan [1 ]
Zhang, Huimin [1 ]
Li, Siting [1 ]
Tang, Mengfan [1 ]
Feng, Xu [1 ]
Yu, Bin [1 ]
Chen, Zhen [1 ]
Wang, Shimin [1 ]
Yin, Ling [1 ]
Mou, Lisha [2 ]
Hart, Traver [3 ]
Chen, Junjie [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
[2] Shenzhen Univ, Shenzhen Peoples Hosp 2, Shenzhen Inst Translat Med, Hlth Sci Ctr,Dept Hepatopancreatobiliary Surg,Affi, Shenzhen, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
关键词
STRAND BREAK REPAIR; ATAXIA-TELANGIECTASIA; REPRESSOR DOMAIN; MESSENGER-RNA; TIF1; BETA; ATM; PRMT5; TRANSCRIPTION; REPLICATION; CHAPERONIN;
D O I
10.1016/j.molcel.2023.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA damage-activated signaling pathways are critical for coordinating multiple cellular processes, which must be tightly regulated to maintain genome stability. To provide a comprehensive and unbiased perspective of DNA damage response (DDR) signaling pathways, we performed 30 fluorescence-activated cell sorting (FACS)-based genome-wide CRISPR screens in human cell lines with antibodies recognizing distinct endogenous DNA damage signaling proteins to identify critical regulators involved in DDR. We discovered that proteasome-mediated processing is an early and prerequisite event for cells to trigger camptothecinand etoposide-induced DDR signaling. Furthermore, we identified PRMT1 and PRMT5 as modulators that regulate ATM protein level. Moreover, we discovered that GNB1L is a key regulator of DDR signaling via its role as a co-chaperone specifically regulating PIKK proteins. Collectively, these screens offer a rich resource for further investigation of DDR, which may provide insight into strategies of targeting these DDR pathways to improve therapeutic outcomes.
引用
收藏
页码:2810 / +
页数:26
相关论文
共 90 条
  • [1] Animal Models of Glycogen Storage Disorders
    Akman, H. Orhan
    Raghavan, Adithya
    Craigen, William J.
    [J]. ANIMAL MODELS OF HUMAN DISEASE, 2011, 100 : 369 - 388
  • [2] HTSeq-a Python']Python framework to work with high-throughput sequencing data
    Anders, Simon
    Pyl, Paul Theodor
    Huber, Wolfgang
    [J]. BIOINFORMATICS, 2015, 31 (02) : 166 - 169
  • [3] ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
    Blackford, Andrew N.
    Jackson, Stephen P.
    [J]. MOLECULAR CELL, 2017, 66 (06) : 801 - 817
  • [4] Targeting DNA Repair in Cancer : Beyond PARP Inhibitors
    Brown, Jessica S.
    O'Carrigan, Brent
    Jackson, Stephen P.
    Yap, Timothy A.
    [J]. CANCER DISCOVERY, 2017, 7 (01) : 20 - 37
  • [5] Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling
    Brumbaugh, Justin
    Di Stefano, Bruno
    Wang, Xiuye
    Borkent, Marti
    Forouzmand, Elmira
    Clowers, Katie J.
    Ji, Fei
    Schwarz, Benjamin A.
    Kalocsay, Marian
    Elledge, Stephen J.
    Chen, Yue
    Sadreyev, Ruslan I.
    Gygi, Steven P.
    Hu, Guang
    Shi, Yongsheng
    Hochedlinger, Konrad
    [J]. CELL, 2018, 172 (1-2) : 106 - +
  • [6] Single-strand break repair and genetic disease
    Caldecott, Keith W.
    [J]. NATURE REVIEWS GENETICS, 2008, 9 (08) : 619 - 631
  • [7] Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]
  • [8] The DNA Damage Response: Making It Safe to Play with Knives
    Ciccia, Alberto
    Elledge, Stephen J.
    [J]. MOLECULAR CELL, 2010, 40 (02) : 179 - 204
  • [9] Biomarker-Guided Development of DNA Repair Inhibitors
    Cleary, James M.
    Aguirre, Andrew J.
    Shapiro, Geoffrey I.
    D'Andrea, Alan D.
    [J]. MOLECULAR CELL, 2020, 78 (06) : 1070 - 1085
  • [10] Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
    Cole, Susan P. C.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 95 - +